Qualigen Therapeutics, Inc.

0.23 USD
+0.02 (+9.52%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Qualigen Therapeutics, Inc. stock is down -20.69% since 30 days ago. The next earnings date is Jul 5, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 9 June’s closed higher than May.

About Qualigen Therapeutics, Inc.

Qualigen Therapeutics, Inc. develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers.